The trajectory of gout: mapping pathogenic cell states from flares to tophus

Clicks: 22
ID: 332607
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #74 of 339 articles by views in Lara D. Veeken

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 339 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract The clinical course of gout is typically divided into four stages: asymptomatic hyperuricemia, gout flares, intercritical gout and tophaceous gout. However, the cellular and molecular mechanisms driving transitions between these stages remain unclear. Current clinical practice lacks stage-specific precision therapeutic strategies. In recent years, the development of single-cell sequencing technologies has provided tools to reveal dynamic cell state transitions during gout progression. This review synthesizes existing single-cell evidence to systematically delineate the immune and stromal cell landscapes across the stages of gout, and explores their roles in inflammation initiation, spontaneous resolution, and tissue remodeling, with the aim to provide a theoretical framework for stage-adapted therapies.
Reference Key
openalex_W7222736318 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Lara D. Veeken
Year 2026
DOI
10.1093/rheumatology/keag581
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.